Biased α-adrenergic receptor and βarrestin signaling in a cell culture model of benign prostatic hyperplasia
- 1 February 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 471 (1) , 41-46
Abstract
No abstract availableKeywords
Funding Information
- Haskell Hess professorship
This publication has 22 references indexed in Scilit:
- Coupling of α1-Adrenoceptors to ERK1/2 in the Human ProstateUrologia Internationalis, 2011
- Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk FactorsCurrent Bladder Dysfunction Reports, 2010
- Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate CancerCancer Research, 2007
- Adipocyte functions are modulated by cell size change: potential involvement of an integrin/ERK signalling pathwayInternational Journal of Obesity, 2003
- Norepinephrine activates P44 and P42 MAPK in human prostate stromal and smooth muscle cells but not in epithelial cellsThe Prostate, 2003
- The role of α 1 ‐adrenergic receptor subtypesin lower urinary tract symptomsBJU International, 2001
- Molecular ‘palpation’ of BPH: a tale of MAPK signalling?Trends in Molecular Medicine, 2001
- Modulation of the differentiation status of cultured prostatic smooth muscle cells by an ?1-adrenergic receptor antagonistThe Prostate, 1999
- Transforming growth factor β1 transduced mouse prostate reconstitutions: II. Induction of apoptosis by doxazosinThe Prostate, 1997
- The alpha‐adrenoceptor subtype mediating the tension of human prostatic smooth muscleThe Prostate, 1993